Balance Sheet Data

Vaxart Inc

Vaxart Inc (VXRT)

$7.4
0.51 (+7.40%)

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Total Cash 66.8081.7057.6069.002.9911.5113.5326.8129.0131.3933.9636.75
Total Cash (%)
Account Receivables 11.0018.7012.600.700.631.803.623.193.453.744.044.37
Account Receivables (%)
Inventories ------------
Inventories (%)
Accounts Payable 2.402.801.903.901.390.960.851.781.922.082.252.43
Accounts Payable (%)
Capital Expenditure -1.00-0.10-0.10-0.20-0.12-0.71-0.85-0.51-0.55-0.59-0.64-0.70
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.